Publications by authors named "Gail J Roboz"

100Publications

Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy.

Leuk Lymphoma 2020 Oct 10:1-3. Epub 2020 Oct 10.

Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1832674DOI Listing
October 2020

Mapping Local Biospecimen Records to the OMOP Common Data Model.

AMIA Jt Summits Transl Sci Proc 2020 30;2020:422-429. Epub 2020 May 30.

Department of Healthcare Policy & Research, Weill Cornell Medicine, New York, NY.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233045PMC
May 2020

The BiTE (bispecific T-cell engager) platform: Development and future potential of a targeted immuno-oncology therapy across tumor types.

Cancer 2020 Jul 13;126(14):3192-3201. Epub 2020 May 13.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32909DOI Listing
July 2020

The therapeutic landscape for cells engineered with chimeric antigen receptors.

Nat Biotechnol 2020 02 6;38(2):233-244. Epub 2020 Jan 6.

Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41587-019-0329-2DOI Listing
February 2020

Clonal Hematopoiesis and Premalignant Diseases.

Cold Spring Harb Perspect Med 2020 04 1;10(4). Epub 2020 Apr 1.

Division of Hematology & Oncology, Weill Cornell Medical College, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/cshperspect.a035675DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117948PMC
April 2020

Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia.

Clin Epigenetics 2019 07 22;11(1):106. Epub 2019 Jul 22.

Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13148-019-0704-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647096PMC
July 2019

Clonal Hematopoiesis and risk of Acute Myeloid Leukemia.

Best Pract Res Clin Haematol 2019 06 24;32(2):177-185. Epub 2019 May 24.

Division of Hematology & Oncology, Weill Cornell Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2019.05.007DOI Listing
June 2019

Telomere Trimming and DNA Damage as Signatures of High Risk Neuroblastoma.

Neoplasia 2019 07 23;21(7):689-701. Epub 2019 May 23.

Department of Microbiology & Immunology, W. R. Hearst Microbiology Research Center, Weill Cornell Medical College, New York, NY, USA; Sandra and Edward Meyer Cancer Center, Weill Cornell Medical College, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14765586193008
Publisher Site
http://dx.doi.org/10.1016/j.neo.2019.04.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535646PMC
July 2019

Clonal Hematopoiesis and therapy related MDS/AML.

Best Pract Res Clin Haematol 2019 03 15;32(1):13-23. Epub 2019 Feb 15.

Division of Hematology & Oncology, Weill Cornell Medicine, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2019.02.006DOI Listing
March 2019

Low clinical trial accrual of patients with myelodysplastic syndromes: Causes and potential solutions.

Cancer 2018 12 5;124(24):4601-4609. Epub 2018 Oct 5.

Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31769
Publisher Site
http://dx.doi.org/10.1002/cncr.31769DOI Listing
December 2018

Evaluating Generalizability of a Biospecimen Informatics Approach: Support for Local Requirements and Best Practices.

AMIA Jt Summits Transl Sci Proc 2018 18;2017:55-62. Epub 2018 May 18.

Information Technologies and Services Department, Weill Cornell Medicine, New York, NY.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961803PMC
May 2018

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.

N Engl J Med 2018 Jun 2;378(25):2386-2398. Epub 2018 Jun 2.

From the University of Texas M.D. Anderson Cancer Center, Houston (C.D.D., H.M.K.); Memorial Sloan Kettering Cancer Center (E.M.S., M.S.T.) and Weill Cornell Medical College (G.J.R.), New York; Institut Gustave Roussy, Villejuif (S.B., C.W.), and Centre Hospitalier Universitaire Bordeaux, Bordeaux (A.P.) - both in France; Northwestern University, Chicago (J.K.A.); Ohio State University Wexner Medical Center, Columbus (A.S.M.); Sylvester Comprehensive Cancer Center, University of Miami, Miami (R.S.); University of Texas Southwestern Medical Center, Dallas (R.H.C.); University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco (G.N.M.), and City of Hope Medical Center, Duarte (A.S.S.) - both in California; University of Colorado School of Medicine, Aurora (D.A.P.); Sarah Cannon Research Institute, Nashville (W.D.); Massachusetts General Hospital Cancer Center (A.T.F.) and Dana-Farber Cancer Institute (R.M.S.), Boston, and Agios Pharmaceuticals, Cambridge (S.C., H.W., V.Z., K.E.Y., S.M.K., H.Y., D.D., B.F., M.G., H.L., S.A., B.W., E.C.A.) - all in Massachusetts; University of Alabama at Birmingham, Birmingham (H.P.E.); Johns Hopkins University, Baltimore (G.T.P.); Washington University School of Medicine, St. Louis (G.L.U.); Mayo Clinic, Jacksonville, FL (J.M.F.); Oregon Health and Science University Knight Cancer Institute, Portland (E.T.); Hollings Cancer Center, Medical University of South Carolina, Charleston (R.K.S.); Winship Cancer Institute of Emory University, Atlanta (M.L.A.); Mayo Clinic, Phoenix, AZ (J.L.S.); and Cleveland Clinic, Cleveland (M.A.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1716984DOI Listing
June 2018

Enasidenib for relapsed/refractory acute myeloid leukemia with IDH2 mutations: optimizing the patient experience.

Authors:
Gail J Roboz

Clin Adv Hematol Oncol 2018 May;16(5):322-325

Clinical and Translational Leukemia Programs, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, New York.

View Article

Download full-text PDF

Source
May 2018

Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia.

Haematologica 2018 08 3;103(8):1308-1316. Epub 2018 May 3.

Division of Hematology and Medical Oncology, Leukemia Program, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2017.183418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068018PMC
August 2018

CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine.

Leuk Lymphoma 2018 04 18;59(4):821-828. Epub 2017 Jul 18.

a Department of Medicine, Division of Hematology and Medical Oncology , Weill Cornell Medicine , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1352089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773411PMC
April 2018

Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia.

J Clin Oncol 2017 Aug 27;35(23):2708-2715. Epub 2017 Jun 27.

All authors: Weill Cornell Medicine and New York Presbyterian Hospital, New York NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.6745DOI Listing
August 2017

Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations.

J Mol Diagn 2017 07 16;19(4):537-548. Epub 2017 May 16.

Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2017.03.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500824PMC
July 2017

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.

J Clin Oncol 2017 May 28;35(14):1591-1597. Epub 2017 Mar 28.

Sophie Park, Centre Hospitalier Universitaire (CHU) Grenoble Alpes, Université Grenoble Alpes, Grenoble; Jean-François Hamel and Sylvain Thépot, CHU d'Angers; Sylvain Thépot, Université d'Angers, Institut National de la Santé et de la Recherche Médicale, Unité 1232, and LabEx IGO, Angers; Andrea Toma, CHU Henri Mondor, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris-Est Créteil; Rosa Sapena and Pierre Fenaux, CHU Saint Louis, AP-HP, Université Paris X; François Dreyfus, CHU Cochin, AP-HP, Université Paris V, Paris; Charikleia Kelaidi, CHU Avicenne, Avicenne; Odile Beyne-Rauzy, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse; Aspasia Stamatoullas, Centre Henri Becquerel, Rouen; Agnès Guerci-Bresler, CHU Nancy, Nancy; Dominique Bordessoule, CHU Dupuytren, Limoges; Pascale Cony-Makhoul, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy; Stéphane Cheze, CHU de Caen, Caen; Eric Wattel, Centre Hospitalier Lyon-Sud, Pierre Bénite, Lyon; Christian Rose, Université Catholique de Lille, Lille; Norbert Vey, Institut Paoli-Calmettes Marseille, Marseille, France; Maria Diez Campelo, Hospital Universitario de Salamanca, Salamanca; Teresa Bernal, Hospital Central de Asturias, Oviedo; Fernando Ramos, Hospital de León, León; Marisa Calabuig, Hospital Clínico de Valencia; Guillermo F. Sanz, Hospital Universitario y Politecnico La Fe, Valencia, Spain; Valeria Santini and Alessandro Sanna, Azienda Ospedaliero Universitaria (AOU) Careggi and University of Florence, Florence; Enrico Balleari, Istituto di Ricovero e Cura a Carattere Scientifico AOU San Martino di Genova, Genova; Daniela Gioia, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria; Dario Ferrero, Università degli Studi di Torino; Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Torino; Giovanni Cametti, Ospedale Maggiore di Chieri, Chieri; Fabrizio Pane, Università Federico II, Napoli, Italy; Mikkael A. Sekeres and Jaime Fensterl, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Rami Komrokji, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; David P. Steensma, Dana-Farber Cancer Institute, Boston, MA; Gail J. Roboz, Weill Medical College of Cornell University, New York, NY; Jennifer Kaivers and Ulrich Germing, University of Düsseldorf, Düsseldorf; Katharina Götze and Catharina Müller-Thomas, Universität München, München, Germany; and Ioannis Kotsianidis, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.3271DOI Listing
May 2017

The application of mass spectrometry to leukemia drug discovery.

Expert Opin Drug Discov 2016 11 23;11(11):1029-1032. Epub 2016 Sep 23.

b Department of Medicine, Division of Hematology/Oncology , Icahn School of Medicine of Mount Sinai , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17460441.2016.1233175DOI Listing
November 2016

Are we ready for precision medicine in acute myeloid leukemia?

Authors:
Gail J Roboz

Clin Adv Hematol Oncol 2016 Aug;14(8):582-4

Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York.

View Article

Download full-text PDF

Source
August 2016

Clofarabine as a bridge to hematopoietic stem cell transplant.

Leuk Lymphoma 2017 01 31;58(1):230-232. Epub 2016 May 31.

d Department of Hematology/Oncology , University of Chicago , 5841 South Maryland , Chicago , IL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1185784DOI Listing
January 2017

Evolving treatments in acute myeloid leukemia.

Authors:
Gail J Roboz

Clin Adv Hematol Oncol 2015 Feb;13(2):93-5

New York Presbyterian Hospital, New York, NY.

View Article

Download full-text PDF

Source
February 2015

Advances in the treatment of relapsed/refractory acute lymphoblastic leukemia: a case study compendium.

Clin Adv Hematol Oncol 2014 Dec;12(12 Suppl 20):8-18, 1

Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
December 2014

Mass spectrometry in leukemia research and treatment.

Expert Rev Hematol 2015 Apr 26;8(2):225-35. Epub 2015 Feb 26.

Department of Medicine, Division of Hematology/Oncology, Icahn School of Medicine of Mount Sinai, New York, NY, 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2015.1018889DOI Listing
April 2015

Epigenetic targeting and personalized approaches for AML.

Authors:
Gail J Roboz

Hematology Am Soc Hematol Educ Program 2014 Dec 18;2014(1):44-51. Epub 2014 Nov 18.

Leukemia Program, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2014.1.44DOI Listing
December 2014

Prevalence, management, and clinical consequences of QT interval prolongation during treatment with arsenic trioxide.

J Clin Oncol 2014 Nov 22;32(33):3723-8. Epub 2014 Sep 22.

Gail J. Roboz, Ellen K. Ritchie, Tania J. Curcio, Eric J. Feldman, and Paul D. Kligfield, Weill Medical College of Cornell University and New York-Presbyterian Hospital; Michael Samuel, Montefiore Medical Center and Albert Einstein College of Medicine; Juliette L. Provenzano-Gober, New York University, New York, NY; Rebecca F. Carlin, Greater Baltimore Medical Center, Baltimore, MD; and Leanne Gale, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.2913DOI Listing
November 2014

International randomized phase III study of elacytarabine versus investigator choice in patients with relapsed/refractory acute myeloid leukemia.

J Clin Oncol 2014 Jun 19;32(18):1919-26. Epub 2014 May 19.

Gail J. Roboz, Weill Cornell Medical College and the New York Presbyterian Hospital; Todd Rosenblat, Columbia University Medical Center, New York, NY; Martha Arellano, Winship Cancer Institute at Emory University; Scott R. Solomon, The Blood and Marrow Transplant Group of Georgia, Atlanta, GA; Jessica K. Altman, Francis J. Giles, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Casey O'Connell, University of Southern California Norris Comprehensive Cancer Center and Hospital, Los Angeles, CA; Marco Gobbi, Azienda Ospedaliera Universitaria San Martino, University of Genoa, Genoa, Italy; Pau Montesinos, Hospital Universitario y Politécnico La Fé, Valencia, Spain; Arnaud Pigneux, Centre Hospitalier Universitaire de Bordeaux Hôpital Haut-Lévêque, Pessac; Norbert Vey, L'Institut Paoli-Calmettes, Marseilles, France; Robert Hills, Cardiff University School of Medicine, Cardiff, United Kingdom; Tove Flem Jacobsen, Athos Gianella-Borradori, Øivind Foss, and Sylvia Vetrhus, Clavis Pharma ASA, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.8562DOI Listing
June 2014

Standardizing the initial evaluation for myelodysplastic syndromes.

Curr Hematol Malig Rep 2013 Dec;8(4):361-9

Department of Medicine, Weill Medical College of Cornell University, 515 E. 71st Street, "S" Building, Room S262, New York, NY, 10021, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-013-0180-3DOI Listing
December 2013

Pregnancy in a woman with chronic neutrophilic leukemia.

Obstet Gynecol 2013 Feb;121(2 Pt 2 Suppl 1):457-60

Department of Obstetrics and Gynecology, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/aog.0b013e3182736e76DOI Listing
February 2013

Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia.

Leuk Lymphoma 2013 Sep 7;54(9):2003-7. Epub 2013 Feb 7.

Leukemia Program, Weill Medical College of Cornell University and The New York Presbyterian Hospital, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.762093DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888021PMC
September 2013

Current treatment of acute myeloid leukemia.

Authors:
Gail J Roboz

Curr Opin Oncol 2012 Nov;24(6):711-9

Leukemia Program, Weill Medical College of Cornell University, The New York Presbyterian Hospital, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e328358f62dDOI Listing
November 2012

Are low-intensity induction strategies better for older patients with acute myeloid leukemia?

Leuk Res 2012 Apr 8;36(4):407-12. Epub 2012 Feb 8.

Leukemia Program, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, NY 10065, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.12.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626084PMC
April 2012

Novel approaches to the treatment of acute myeloid leukemia.

Authors:
Gail J Roboz

Hematology Am Soc Hematol Educ Program 2011 ;2011:43-50

Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://www.asheducationbook.org/cgi/doi/10.1182/asheducation
Publisher Site
http://dx.doi.org/10.1182/asheducation-2011.1.43DOI Listing
April 2012

Acute myeloid leukemia stem cells: seek and destroy.

Expert Rev Hematol 2009 Dec;2(6):663-72

Weill Medical College of Cornell University, The New York Presbyterian Hospital, 520 East 70th Street, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ehm.09.53DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677185PMC
December 2009

Arsenic trioxide and low-dose cytarabine for patients with intermediate-2 and high-risk myelodysplastic syndrome.

Leuk Res 2011 Apr 16;35(4):522-5. Epub 2010 Oct 16.

Leukemia Program, Weill Medical College of Cornell University, The New York Presbyterian Hospital, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S014521261000456
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2010.09.010DOI Listing
April 2011

Levels of care: defining best supportive care in elderly patients with acute myeloid leukemia.

Curr Hematol Malig Rep 2010 Apr;5(2):95-100

Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-010-0048-8DOI Listing
April 2010

A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response.

Blood 2009 Apr 24;113(17):3938-46. Epub 2008 Nov 24.

Department of Oncology, Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2008-09-17
Publisher Site
http://dx.doi.org/10.1182/blood-2008-09-177030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673122PMC
April 2009

Arsenic and old lace: novel approaches in elderly patients with acute myeloid leukemia.

Authors:
Gail J Roboz

Semin Hematol 2008 Jul;45(3 Suppl 2):S22-4

Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2008.07.005DOI Listing
July 2008